NOV 06, 2017 05:15 AM PST

Strep Vaccine Could Prevent Thousands of Stillbirths and Infant Deaths

WRITTEN BY: Kara Marker

Around the world pregnant women and their babies are at risk of a bacterial infection that is a major cause of maternal and infant death, and there is no vaccine to prevent it. A new study lead by the London School of Hygiene & Tropical Medicine is the first comprehensive study of Group B streptococcus (GBS) bacteria, looking at disease burden worldwide as opposed to high-income countries.

GBS can cause disease in anyone, but it is most known for its connection to severe newborn infections. Nearly one-third of the world’s adult population can carry GBS bacteria without ever knowing it, meaning that in can easily be passed to a fetus, which is much more vulnerable to the infection while it is still developing.

Experts estimate that 20 percent of pregnant women develop infections caused by GBS bacteria, which can lead to meningitis and septicemia for both mother and baby. And long-lasting health problems develop for the babies that do survive, including hearing loss, vision loss, and cerebral palsy.

"The first few days and weeks of a baby's life are the most vulnerable - by far,” said Dr. Keith Klugman from the Bill & Melinda Gates Foundation, which funded the study. “By filling in one of the great voids in public health data, this work provides crucial insight and shows the pressing unmet need for the development of an effective Group B Strep vaccine.”

The study shows that approximately 410,000 annual GBS infections occur worldwide, with 147,000 resulting in stillbirth or other infant deaths. The highest burden is in Africa, which accounts for 65 percent of all stillbirths and infant deaths. The new study provides all kinds of information on GBS and pregnancy: how many women are at risk, what the outcomes are for mother and baby. It also showed how a maternal GBS vaccine was 80 percent effective and reached 90 percent of women and that it could prevent 231,000 infant and maternal GBS cases.

Vaccines to prevent GBS are in the works, but what’s available now? Antibiotics are given to women in labor to prevent passing the disease to infants during delivery, but there’s a chance that the baby has already come into contact with GBS. However, GBS bacteria grow back quickly, so antibiotics cannot be taken earlier than during labor.

Co-lead researcher of the study Joy Lawn estimates that 29,000 cases of GBS are prevented by the current antibiotic approach, but almost all of those prevented cases are in high-income countries.

“A maternal GBS vaccine could prevent many more cases and deaths worldwide,” explained another co-lead researcher, Anna Seale. The research team from the London School of Hygiene & Tropical Medicine plans on continuing their studies by looking at cost-effectiveness evaluation of developing a GBS vaccine.

"Too many parents around the world face the death of a baby or a young child,” Lawn said. “Avoidable GBS deaths are happening in every country.”

The present study was published in the journal Clinical Infectious Diseases.

Sources: CDC, London School of Hygiene & Tropical Medicine

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog:
You May Also Like
MAY 22, 2018
MAY 22, 2018
Novel PD-L1/TGF-ß Fusion Protein for HPV-Associated Cancers Enters Phase II Clinical Trial
Novel PD-L1/TGF-ß fusion protein for HPV-associated cancers enters phase II clinical trial. Oncology researchers excited about the potential of this bi-functional protein to combat cancer...
JUN 15, 2018
JUN 15, 2018
Red Meat Allergy Causes Heart Disease
For people with an uncommon sensitivity to a particular carbohydrate in red meat, the risk of heart disease is elevated when consumed. From the National He...
JUL 10, 2018
Health & Medicine
JUL 10, 2018
Towards a Universal Flu Vaccine
Each year, depending on the weather and other factors, flu season shows up and sometimes it’s really bad and other times it’s not as widespread...
JUL 11, 2018
JUL 11, 2018
The Power of Seal Serum
Unlike humans, seals remain uninjured despite repeated deep dives to hunt. Scientists have shown that serum from seals blood provides anti-inflammatory properties that lower immune response....
JUL 24, 2018
JUL 24, 2018
Measles are on the Move
Measles is a highly contagious disease that used to be common in young children. Due to the development of vaccines, however, it’s been almost eradic...
AUG 28, 2018
Drug Discovery
AUG 28, 2018
Combination Therapy for Advanced Melonoma
According to a research study led by UCLA, a bacteria-like agent used in combination with an immunotherapeutic drug may help patients survive longer with a...
Loading Comments...